Advertisement
Screener

LEXICON PHARMACEUTICALS, INC. (LXRX) Form D

LEXICON PHARMACEUTICALS, INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2023-06-20: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2023-06-05; Total offering amount $72,215,130.
  • 2022-08-03: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2022-08-01; Total offering amount $49,324,650.
  • 2017-03-24: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2017-03-21; Total offering amount $10,506,500.
  • 2014-12-12: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2014-12-04; Total offering amount $4,662,780.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2023-06-20Rule 506(b)Equity2023-06-05$72,215,130$72,215,130$01
2022-08-03Rule 506(b)Equity2022-08-01$49,324,650$42,891,000$6,433,6502
2017-03-24Rule 506(b)Equity2017-03-21$10,506,500$10,506,500$016
2014-12-12Rule 506(b)Equity2014-12-04$4,662,780$4,662,780$016
2014-12-08Rule 506(b)Equity2014-11-26$150,000,000$150,000,000$01
2012-08-07Rule 506Equity2012-07-30$35,000,000$35,000,000$016
2010-03-31Rule 506Equity2010-03-19$75,035,737$75,035,737$02

Similar stocks

Stock NameCountryMarket CapPE Ratio
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
GERON CORP (GERN)United States$0.803B-12.14
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78